0001209191-21-049938.txt : 20210805
0001209191-21-049938.hdr.sgml : 20210805
20210805162818
ACCESSION NUMBER: 0001209191-21-049938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210803
FILED AS OF DATE: 20210805
DATE AS OF CHANGE: 20210805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lambert Nicole
CENTRAL INDEX KEY: 0001770252
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38419
FILM NUMBER: 211148727
MAIL ADDRESS:
STREET 1: 320 WAKARA WAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcus Biosciences, Inc.
CENTRAL INDEX KEY: 0001724521
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473898435
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 694-6200
MAIL ADDRESS:
STREET 1: 3928 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-03
0
0001724521
Arcus Biosciences, Inc.
RCUS
0001770252
Lambert Nicole
C/O ARCUS BIOSCIENCES, INC.
3928 POINT EDEN WAY
HAYWARD
CA
94545
1
0
0
0
Common Stock
2021-08-03
4
A
0
4700
0.00
A
4700
D
Stock Option (Right to Buy)
30.02
2021-08-03
4
A
0
21700
0.00
A
2031-08-02
Common Stock
21700
21700
D
Represents the grant of restricted stock units that vest in three equal annual installments on each of September 15, 2022, September 15, 2023, and September 15, 2024, subject to the Reporting Person's continued service to the Company.
The option is exercisable in 36 equal monthly installments after August 3, 2021, subject to the Reporting Person's continued service to the Company.
/s/ Carolyn Tang, Attorney-in-Fact
2021-08-05